Ont Health Technol Assess Ser. 2019 Feb 19;19(2):1-86. eCollection 2019.
People with chronic venous insufficiency who develop leg ulcers face a difficult condition to treat. Venous leg ulcers may persist for long periods of time and have a negative impact on quality of life. Treatment requires frequent health care provider visits, creating a substantial burden across health care settings.The objective of this health technology assessment was to evaluate the effectiveness, safety, cost-effectiveness, budget impact, and patient experiences of compression stockings for prevention of venous leg ulcer recurrence.
We conducted a systematic review of the literature to identify randomized trials and observational studies examining the effectiveness of compression stockings in reducing the risk of recurrence of venous leg ulcers after healing and/or reported on the quality of life for patients and any adverse events from the wearing of compression stockings. We performed a literature search to identify studies and evaluated the quality of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.We conducted a cost-utility analysis with a 5-year time horizon from the perspective of the Ontario Ministry of Health and Long-Term Care. We compared compression stockings to usual care (no compression stockings) and simulated a hypothetical cohort of 65-year-old patients with healed venous ulcers, using a Markov model. Model input parameters were obtained primarily from the published literature. In addition, we used Ontario costing sources and consultation with clinical experts. We estimated quality-adjusted life years gained and direct medical costs. We conducted sensitivity analyses and a budget impact analysis to estimate the additional costs required to publicly fund compression stockings in Ontario. All costs are presented in 2018 Canadian dollars.We spoke to people who recently began using compression stockings and those who have used them for many years to gain an understanding of their day-to-day experience with the management of chronic venous insufficiency and compression stockings.
One randomized controlled trial reported that the recurrence rate was significantly lower at 12 months in people who were assigned to the compression stocking group compared with people assigned to the control group (risk ratio 0.43, 95% CI, 0.27-0.69; = .001) (GRADE: Moderate). Three randomized controlled trials reported no significant difference in recurrence rates between the levels of pressure. One randomized controlled trial also reported that the risk of recurrence was six times higher in those who did not adhere to compression stockings than in those who did adhere. One single-arm cohort study showed that the recurrence rate was considerably higher in people who did not adhere or had poor adherence (79%) compared with those who adhered to compression stockings (4%).Compared with usual care, compression stockings were associated with higher costs and with increased quality-adjusted life years. We estimated that, on average, the incremental cost-effectiveness ratio of compression stockings was $27,300 per quality-adjusted life year gained compared to no compression stockings. There was some uncertainty in our results, but most simulations (> 70%) showed that the incremental cost-effectiveness ratio remained below $50,000 per quality-adjusted life-year. We estimated that the annual budget impact of funding compression stockings would range between $0.95 million and $3.19 million per year over the next five years.People interviewed commonly reported that chronic venous insufficiency had a substantial impact on their day-to-day lives. There were social impacts from the difficulty or inability to walk and emotional impacts from the loss of independence and fear of ulcer recurrence. There were barriers to the wearing of compression stockings, including replacement cost and the difficulty of putting them on; however, most people interviewed reported that using compression stockings improved their condition and their quality of life.
The available evidence shows that, compared with usual care, compression stockings are effective in preventing venous leg ulcer recurrence and likely to be cost-effective. In people with a healed venous leg ulcer, wearing compression stockings helps to reduce the risk of recurrence by about half. Publicly funding compression stockings for people with venous leg ulcers would result in additional costs to the Ontario health care system over the next 5 years. Despite concerns about cost and the daily chore of wearing compression stockings, most people interviewed felt that compression stockings provided important benefits through reduction of swelling and prevention of recurrence.
患有慢性静脉功能不全且出现腿部溃疡的患者面临着难以治疗的状况。腿部静脉溃疡可能会持续很长时间,并对生活质量产生负面影响。治疗需要患者频繁就医,给整个医疗体系带来了沉重负担。这项卫生技术评估的目的是评估压力袜预防腿部静脉溃疡复发的有效性、安全性、成本效益、预算影响以及患者体验。
我们对文献进行了系统回顾,以确定随机试验和观察性研究,这些研究考察了压力袜在愈合后降低腿部静脉溃疡复发风险的有效性,和/或报告了患者的生活质量以及穿压力袜产生的任何不良事件。我们进行了文献检索以识别研究,并使用推荐分级评估、制定和评价(GRADE)方法评估证据质量。我们从安大略省卫生和长期护理部的角度进行了为期5年的成本效用分析。我们将压力袜与常规护理(不使用压力袜)进行比较,并使用马尔可夫模型模拟了一组假设的65岁腿部静脉溃疡已愈合的患者。模型输入参数主要来自已发表的文献。此外,我们使用了安大略省的成本数据来源并咨询了临床专家。我们估计了获得的质量调整生命年和直接医疗成本。我们进行了敏感性分析和预算影响分析,以估计安大略省为压力袜提供公共资金所需的额外成本。所有成本均以2018年加拿大元表示。我们与最近开始使用压力袜的人和已经使用多年的人进行了交谈,以了解他们在慢性静脉功能不全管理和压力袜使用方面的日常体验。
一项随机对照试验报告称,与对照组相比,分配到压力袜组的患者在12个月时的复发率显著更低(风险比0.43,95%置信区间,0.27 - 0.69;P = 0.001)(GRADE:中等)。三项随机对照试验报告称,不同压力水平之间的复发率无显著差异。一项随机对照试验还报告称,不坚持使用压力袜的患者复发风险比坚持使用的患者高六倍。一项单臂队列研究表明,不坚持或依从性差的患者(79%)的复发率比坚持使用压力袜的患者(4%)高得多。与常规护理相比,压力袜成本更高,但质量调整生命年增加。我们估计,与不使用压力袜相比,压力袜的平均增量成本效益比为每获得一个质量调整生命年27,300加元。我们的结果存在一些不确定性,但大多数模拟(> 70%)表明,增量成本效益比仍低于每质量调整生命年50,000加元。我们估计,在未来五年中,为压力袜提供资金的年度预算影响将在每年95万加元至319万加元之间变动。接受采访的人普遍报告称,慢性静脉功能不全对他们的日常生活有重大影响。因行走困难或无法行走产生了社会影响,因失去独立性和担心溃疡复发产生了情绪影响。穿压力袜存在一些障碍,包括更换成本和穿戴困难;然而,大多数接受采访的人报告称,使用压力袜改善了他们的病情和生活质量。
现有证据表明,与常规护理相比,压力袜在预防腿部静脉溃疡复发方面有效,并且可能具有成本效益。在腿部静脉溃疡已愈合的患者中,穿压力袜有助于将复发风险降低约一半。在未来5年中,为腿部静脉溃疡患者提供压力袜的公共资金将给安大略省医疗系统带来额外成本。尽管人们担心成本以及穿压力袜的日常麻烦,但大多数接受采访的人认为,压力袜通过减轻肿胀和预防复发带来了重要益处。